References
Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L. Prevalence, incidence, and mortality of stroke in china: results from a nationwide population-based survey of 480 687 adults. Circulation 2017, 135: 759–771.
Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019, 394: 1145–1158.
Qiu S, Xu Y. Guidelines for acute ischemic stroke treatment. Neurosci Bull 2020, 36: 1229–1232.
Yang P, Zhang Y, Zhang L, Zhang Y, Treurniet KM, Chen W, et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med 2020, 382: 1981–1993.
Tian D, Yang Q, Dong Q, Li N, Yan B, Fan D. Trends in stroke subtypes and vascular risk factors in a stroke center in China over 10 years. Sci Rep 2018, 8: 5037.
Langhorne P, O’Donnell MJ, Chin SL, Zhang H, Xavier D, Avezum A, et al. Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study. Lancet 2018, 391: 2019–2027.
Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol 2019, 18: 394–405.
Chalos V, LeCouffe NE, Uyttenboogaart M, Lingsma HF, Mulder M, Venema E, et al. Endovascular treatment with or without prior intravenous alteplase for acute ischemic stroke. J Am Heart Assoc 2019, 8: e011592.
Coutinho JM, Liebeskind DS, Slater LA, Nogueira RG, Clark W, Davalos A, et al. Combined intravenous thrombolysis and thrombectomy vs thrombectomy alone for acute ischemic stroke: A pooled analysis of the SWIFT and STAR studies. JAMA Neurol 2017, 74: 268–274.
Bellwald S, Weber R, Dobrocky T, Nordmeyer H, Jung S, Hadisurya J, et al. Direct mechanical intervention versus bridging therapy in stroke patients eligible for intravenous thrombolysis: A pooled analysis of 2 registries. Stroke 2017, 48: 3282–3288.
Suzuki K, Kimura K, Takeuchi M, Morimoto M, Kanazawa R, Kamiya Y, et al. The randomized study of endovascular therapy with versus without intravenous tissue plasminogen activator in acute stroke with ICA and M1 occlusion (SKIP study). Int J Stroke 2019, 14: 752–755.
Acknowledgements
This research highlight was supported by the Clinical Medical Research Expert Training Program of Daping Hospital, China (2018XLC2022).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, WX., Huang, SH., Wang, YJ. et al. Recanalization Treatment for Acute Stroke: Can We Skip the Bridge?. Neurosci. Bull. 37, 585–587 (2021). https://doi.org/10.1007/s12264-021-00658-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12264-021-00658-z